Zentalis Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Zentalis Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q2 2024.
  • Zentalis Pharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -35.6 %, a 32% increase year-over-year.
  • Zentalis Pharmaceuticals, Inc. annual Return On Assets for 2023 was -52 %, a 12.1% decline from 2022.
  • Zentalis Pharmaceuticals, Inc. annual Return On Assets for 2022 was -46.4 %, a 9.72% decline from 2021.
  • Zentalis Pharmaceuticals, Inc. annual Return On Assets for 2021 was -42.3 %, a 1.03% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -35.6 +16.7 +32% Apr 1, 2024 Jun 30, 2024
Q1 2024 -37.8 +7.54 +16.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -52 -5.6 -12.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -51.2 -3.82 -8.06% Jul 1, 2023 Sep 30, 2023
Q2 2023 -52.3 -13.3 -34.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -45.3 -2.81 -6.61% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46.4 -4.11 -9.72% Oct 1, 2022 Dec 31, 2022
Q3 2022 -47.4 -5.22 -12.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -39 +13.3 +25.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -42.5 +2.58 +5.72% Jan 1, 2022 Mar 31, 2022
Q4 2021 -42.3 +0.44 +1.03% Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.2 +2.42 +5.43% Jul 1, 2021 Sep 30, 2021
Q2 2021 -52.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 -45.1 Jan 1, 2021 Mar 31, 2021
Q4 2020 -42.7 Oct 1, 2020 Dec 31, 2020
Q3 2020 -44.6 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.